Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Acarbose 50 mg, 100 mg tablets Bayer AG, Leverkusen, Germany Glucobay Paracetamol 60 mg, 125 mg, 500 mg suppositories Astra Pharmaceutical Production AB, Karlskoga, Sweden Daunorubicin hydrochloride 21.4 mg in 4 ml (equivalent to 20 mg daunorubicin) injection (vial) DBL Australia Pty Limited, Mulgrave North, Victoria, Australia Azithromycin dihydrate equivalent to 250 mg azithromycin base capsule Pfizer Limited, Sandwich, Kent, England and Pfizer Italiana S.p.A., Latina, Italy Zithromax Azithromycin dihydrate equivalent to 200 mg/ml azithromycin base powder for oral suspension Pfizer Limited, Sandwich, Kent, England and Pfizer Italiana S.p.A., Latina, Italy Zithromax Murine MAB to Beta hCG 1.8 mcg and Murine to Alpha hCG 0.9 mcg pregnancy test kit Syntron Bioresearch Inc., Vista, California, United States of America Clarity Instant Pregnancy Test Murine MAB to Beta hCG 1.8 mcg and Murine to Alpha hCG 0.9 mcg pregnancy test kit Syntron Bioresearch Inc., Vista, California, United States of America New Zealand Diagnostics Instant Pregnancy Test Antihemophilic factor (recombinant) rAHF 250IU, 500IU, 1000IU injection (vial) Baxter Healthcare Corporation, Glendale, California, United States of America Recombinate Dated this 10th day of December 1993. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.